XML 41 R58.htm IDEA: XBRL DOCUMENT v3.20.1
Common Stock, and Warrants With-Down Round Protection - Schedule of Fair Value Assumptions (Details)
Dec. 31, 2019
$ / shares
Dec. 31, 2018
$ / shares
Warrants and rights outstanding, measurement input, term 5 years  
Share price [1] $ 0.258 $ 2.45
Minimum [Member]    
Warrants and rights outstanding, measurement input, per share 0.258  
Maximum [Member]    
Warrants and rights outstanding, measurement input, per share 5.400  
Warrant [Member]    
Warrants and rights outstanding, measurement input, per share   0.258
Fair value   $ 0.13
Warrant [Member] | Minimum [Member]    
Fair value 0.003  
Warrant [Member] | Maximum [Member]    
Fair value $ 0.134  
Dividend Yield [Member]    
Warrants and rights outstanding, measurement input, percentages 0  
Dividend Yield [Member] | Warrant [Member]    
Warrants and rights outstanding, measurement input, percentages 0.00 0.00
Expected Volatility [Member]    
Warrants and rights outstanding, measurement input, percentages [2] 56.21  
Expected Volatility [Member] | Warrant [Member]    
Warrants and rights outstanding, measurement input, percentages 56.32 56.32
Risk Free Interest Rate [Member]    
Warrants and rights outstanding, measurement input, percentages 2.5  
Risk Free Interest Rate [Member] | Warrant [Member]    
Warrants and rights outstanding, measurement input, percentages 2.5 2.5
Expected Term of Options [Member] | Warrant [Member]    
Warrants and rights outstanding, measurement input, term 5 years 5 years
Exercise Price [Member] | Warrant [Member]    
Warrants and rights outstanding, measurement input, per share   $ 0.258
Exercise Price [Member] | Warrant [Member] | Minimum [Member]    
Warrants and rights outstanding, measurement input, per share $ 0.258  
Exercise Price [Member] | Warrant [Member] | Maximum [Member]    
Warrants and rights outstanding, measurement input, per share 5.400  
Share Price [Member] | Warrant [Member]    
Share price $ 0.258 $ 0.258
[1] The Common Stock price, per share for the year ended December 31, 2019 and 2018 reflects the Company's management's estimation of the fair value per share of Common Stock. In reaching its estimation for December 31, 2018, management considered, among other things, a valuation prepared by a third-party valuation firm following the issuance of the Series D Units.
[2] Due to the low trading volume of the Company's Common Stock, the expected volatility was based on a sample of 248 companies operating in the Healthcare Products industry.